D. Marshall, M. Kotelchuck, T. Young, C. Bose, L. Kruyer et al., Risk Factors for Chronic Lung Disease in the Surfactant Era: A North Carolina Population-based Study of Very Low Birth Weight Infants, PEDIATRICS, vol.104, issue.6, pp.1345-1350, 1999.
DOI : 10.1542/peds.104.6.1345

A. El-hanache, E. Gourrier, P. Karoubi, S. Merbouche, G. Mouchnino et al., Modification of C-reactive protein after instillation of natural exogenous surfactants [Modification de la protéine C réactive après instillation de surfactant exogène naturel in French] Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant?, Arch Pediatr. Acta Paediatr, vol.489, issue.355, pp.27-31556, 1997.

R. Ballard, W. Truog, and A. Cnaan, Inhaled Nitric Oxide in Preterm Infants Undergoing Mechanical Ventilation, New England Journal of Medicine, vol.355, issue.4, pp.343-353, 2006.
DOI : 10.1056/NEJMoa061088

P. Ballard, J. Merrill, and W. Truog, Surfactant Function and Composition in Premature Infants Treated With Inhaled Nitric Oxide, PEDIATRICS, vol.120, issue.2, pp.346-353, 2007.
DOI : 10.1542/peds.2007-0095

J. Davis, R. Parad, M. T. Allred, E. Price, A. Rosenfeld et al., Pulmonary Outcome at 1 Year Corrected Age in Premature Infants Treated at Birth With Recombinant Human CuZn Superoxide Dismutase, PEDIATRICS, vol.111, issue.3, pp.469-476, 2003.
DOI : 10.1542/peds.111.3.469

M. De-hoog, R. Venekamp, and C. Van-der-ent, Impact of early daycare on healthcare resource use related to upper respiratory tract infections during childhood: prospective WHISTLER cohort study, BMC Medicine, vol.17, issue.1, p.107, 2014.
DOI : 10.1007/s10995-012-1125-5